Els M. de Groene

1.0k total citations
22 papers, 865 citations indexed

About

Els M. de Groene is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Els M. de Groene has authored 22 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Cancer Research. Recurrent topics in Els M. de Groene's work include Pharmacogenetics and Drug Metabolism (7 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Els M. de Groene is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Els M. de Groene collaborates with scholars based in Netherlands, India and Germany. Els M. de Groene's co-authors include Johanna Fink‐Gremmels, Gerben Schaaf, Silvia Miret, R.F.M. Maas, Renger F. Witkamp, Sandra M. Nijmeijer, G. Jean Horbach, Peggy Roestenberg, Richard J. Rodenburg and Werner Klaffke and has published in prestigious journals such as Analytical Biochemistry, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

In The Last Decade

Els M. de Groene

21 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Els M. de Groene Netherlands 14 354 258 186 137 117 22 865
Jean‐Claude Béréziat France 19 331 0.9× 206 0.8× 280 1.5× 196 1.4× 95 0.8× 28 1.0k
G. Jean Horbach Netherlands 20 380 1.1× 143 0.6× 247 1.3× 234 1.7× 182 1.6× 45 1.0k
Yuji Ishii Japan 17 408 1.2× 241 0.9× 293 1.6× 90 0.7× 97 0.8× 74 863
Thomas M. Harris United States 16 700 2.0× 301 1.2× 345 1.9× 91 0.7× 69 0.6× 24 1.1k
Jeffrey Lawrence United States 15 601 1.7× 268 1.0× 101 0.5× 130 0.9× 33 0.3× 24 1.1k
Ikuko Ueno Japan 17 399 1.1× 286 1.1× 143 0.8× 95 0.7× 56 0.5× 38 940
William O. Berndt United States 18 272 0.8× 255 1.0× 150 0.8× 121 0.9× 188 1.6× 45 918
John P. Christopher United States 12 363 1.0× 137 0.5× 166 0.9× 88 0.6× 55 0.5× 19 859
Wolfgang Dekant Germany 23 461 1.3× 716 2.8× 532 2.9× 168 1.2× 153 1.3× 41 1.5k
Leane Lehmann Germany 20 380 1.1× 506 2.0× 219 1.2× 78 0.6× 208 1.8× 45 1.4k

Countries citing papers authored by Els M. de Groene

Since Specialization
Citations

This map shows the geographic impact of Els M. de Groene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els M. de Groene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els M. de Groene more than expected).

Fields of papers citing papers by Els M. de Groene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els M. de Groene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els M. de Groene. The network helps show where Els M. de Groene may publish in the future.

Co-authorship network of co-authors of Els M. de Groene

This figure shows the co-authorship network connecting the top 25 collaborators of Els M. de Groene. A scholar is included among the top collaborators of Els M. de Groene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els M. de Groene. Els M. de Groene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Groene, Els M. de & Mariska Dötsch‐Klerk. (2020). From Individual Nutrients to Sustainable Nutrition. World review of nutrition and dietetics. 121. 73–80. 2 indexed citations
3.
Blom, W. Marty, et al.. (2009). A cell-based screening assay for Natural Killer cell activity. International Immunopharmacology. 9(6). 746–752. 4 indexed citations
4.
Miret, Silvia, Els M. de Groene, & Werner Klaffke. (2006). Comparison of In Vitro Assays of Cellular Toxicity in the Human Hepatic Cell Line HepG2. SLAS DISCOVERY. 11(2). 184–193. 86 indexed citations
5.
Gerhardt, Cindy C., et al.. (2005). Comparison of 3 AT1 Receptor Binding Assays: Filtration Assay, ScreenReady™ Target, and WGA Flashplate®. SLAS DISCOVERY. 10(2). 118–126. 6 indexed citations
6.
Verhoeckx, Kitty, Sabina Bijlsma, Els M. de Groene, et al.. (2004). A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. PROTEOMICS. 4(4). 1014–1028. 111 indexed citations
7.
Miret, Silvia, et al.. (2004). Comparison of in Vitro Models for the Prediction of Compound Absorption across the Human Intestinal Mucosa. SLAS DISCOVERY. 9(7). 598–606. 62 indexed citations
8.
Schaaf, Gerben, Sandra M. Nijmeijer, R.F.M. Maas, et al.. (2002). The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1588(2). 149–158. 186 indexed citations
9.
Schaaf, Gerben, R.F.M. Maas, Els M. de Groene, & Johanna Fink‐Gremmels. (2002). Management of Oxidative Stress by Heme Oxygenase-1 in Cisplatin-induced Toxicity in Renal Tubular Cells. Free Radical Research. 36(8). 835–843. 61 indexed citations
10.
Groene, Els M. de, et al.. (2001). Development of an Androgen Reporter Gene Assay (AR-LUX) Utilizing a Human Cell Line with an Endogenously Regulated Androgen Receptor. Analytical Biochemistry. 298(1). 93–102. 66 indexed citations
11.
Schaaf, Gerben, et al.. (2001). Characterization of biotransformation enzyme activities in primary rat proximal tubular cells. Chemico-Biological Interactions. 134(2). 167–190. 31 indexed citations
12.
Groene, Els M. de, et al.. (2000). Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 466(2). 143–159. 21 indexed citations
13.
Wolkers, J., Renger F. Witkamp, Sandra M. Nijmeijer, et al.. (1998). Phase I and phase II enzyme activities in Ringed seals (Phoca hispida): characterization of hepatic cytochrome P450 by activity patterns, inhibition studies, mRNA analyses, and western blotting. Aquatic Toxicology. 44(1-2). 103–115. 47 indexed citations
14.
Natsuhori, Masahiro, M. van Raak, Derk ten Berge, et al.. (1997). Isolation of a bovine full length cytochrome P450 (CYP3A) cDNA sequence and its functional expression in V79 cells. Environmental Toxicology and Pharmacology. 3(1). 17–24. 13 indexed citations
15.
Groene, Els M. de, et al.. (1996). Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. Environmental Toxicology and Pharmacology. 1(1). 21–26. 31 indexed citations
16.
Schneider, Anneliese, Wolfgang A. Schmalix, S. Vasanthi, et al.. (1996). Stable Expression of Human Cytochrome P450 3A4 in Conjunction with Human NADPH-Cytochrome P450 Oxidoreductase in V79 Chinese Hamster Cells. Archives of Biochemistry and Biophysics. 332(2). 295–304. 44 indexed citations
17.
18.
Groene, Els M. de, Willem Seinen, & G. Jean Horbach. (1995). A NIH/3T3 cell line stably expressing human cytochrome P450-3A4 used in combination with a lacZ′ shuttle vector to study mutagenicity. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 293(1). 47–53. 17 indexed citations
19.
Horbach, G. Jean & Els M. de Groene. (1995). Transgenic cell lines and changes in gene function and expression: Useful tools in toxicity testing?. Toxicology in Vitro. 9(4). 509–512. 1 indexed citations
20.
Groene, Els M. de, Sandra M. Nijmeijer, G. Jean Horbach, & Renger F. Witkamp. (1995). Tiamulin inhibits human CYP3A4 activity in an NIH/3T3 cell line stably expressing CYP3A4 cDNA. Biochemical Pharmacology. 50(6). 771–773. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Claude Béréziat Breakdown of academic impact, for papers by G. Jean Horbach Breakdown of academic impact, for papers by Yuji Ishii Breakdown of academic impact, for papers by Thomas M. Harris Breakdown of academic impact, for papers by Jeffrey Lawrence Breakdown of academic impact, for papers by Ikuko Ueno Breakdown of academic impact, for papers by William O. Berndt Breakdown of academic impact, for papers by John P. Christopher Breakdown of academic impact, for papers by Wolfgang Dekant Breakdown of academic impact, for papers by Leane Lehmann
Rankless by CCL
2026